Absorptiometry, Photon; Adult; Aged; Bone Density; Case-Control Studies; Female; Humans; Mass Screening/methods; Middle Aged; Osteoporosis, Postmenopausal/diagnosis/epidemiology/etiology/pathology/radiography; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Severity of Illness Index
Abstract :
[en] According to the recent recommendations of the European Community and the World Health Organization, identification of risk factors for fracture or low bone mineral density (BMD) should help health professionals to make a better use of bone densitometry. This includes helping patients to modify their behaviour and act on modifiable risk factors (correction of low calcium intake and vitamin D deficiencies, etc.) and also to provide evidence-based guidance for starting a treatment when necessary. In this context, we previously developed a clinical scoring index, OSIRIS (OSteoporosis Index of RISk), for classifying women into three categories of risk of osteoporosis. In order to evaluate the discriminatory performance of OSIRIS, we performed the present prospective study in a sample of 889 postmenopausal women from France. The osteoporosis risk depends on the OSIRIS category. Thus, 62% of women in the 'high-risk' category (OSIRIS < or = -3) were osteoporotic, compared to 34% of women in the 'intermediate-risk' category (OSIRIS ranged between -3 and +1) and only 16.8% of women in the 'low-risk' category (score OSIRIS > 1). These results might contribute to the development of more efficient screening strategies for osteoporosis. The patients in the low-risk category do not require immediate BMD testing; women with 'intermediate risk' have to be carefully followed by their doctor with BMD testing decided on a case-by-case basis; for those within the high-risk category, treatment may be initiated immediately and BMD testing performed either to assess the efficacy of the treatment or to increase the long-term compliance of the patient. In conclusion, for clinical practice, a user-friendly tool has been developed. This tool, called OSIRIS, as far as a simple rule allows, identifies the level of osteoporosis risk in women.
Disciplines :
General & internal medicine
Author, co-author :
REGINSTER, Jean-Yves ; Centre Hospitalier Universitaire de Liège - CHU > Médecine de l'appareil locomoteur
Ben Sedrine, Wafa ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Viethel, P.
Micheletti, M. C.
Chevallier, T.
Audran, M.
Language :
English
Title :
Validation of OSIRIS, a prescreening tool for the identification of women with an increased risk of osteoporosis.
Kanis JA, Melton LJ, Christiansen C, et al. The diagnostic of osteoporosis. J Bone Miner Res 1994; 9:1137-41
Lips P. Epidemiology and predictors of fractures associated with osteoporosis. Am J Med 1997;103: 3S-11S
Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. J Am Med Assoc 2001;286:2815-22
Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 1996; 312:1254-9
Genant HK, Cooper C, Poor G. Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 1999;10: 259-64
Kanis JA, Glüer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 2000;11-192-202
The Swedish Council on Technology Assessment in Health Care (SBU). Bone density measurement: a systematic review. J Intern Med 1997;241:1-60
Hailey D, Sampietro-Colom L, Marshall D, et. al. The effectiveness of bone density measurement and associated treatments for prevention of fractures: an international collaborative review. Int J Technol Assess Health Care 1998;14:237-54
Hailey D, Marshall D, Sampietro-Colom L. International collaboration in health technology assessment: a study of technologies used in management of osteoporosis. Health Policy 1998;43:233-41
Kanis JA, Delmas P, Burckhardt P, et al. Guidelines for diagnosis and management of osteoporosis: the European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 1997;7:390-406
Koh LKH, Ng DCE. Osteoporosis risk factor assessment and bone densitometry - current status and future trends. Ann Acad Med 2002;31:37-42
Slemenda CW, Hui SL, Longcope C, et al. Predictors of bone mass in perimenopausal women: a prospective study of clinical data using photon absorptiometry. Ann Intern Med 1990;112:96-101
Kroger H, Tuppurainen M, Honkanen R, et al. Bone mineral density and risk factors for osteoporosis: a population-based study of 1600 perimenopausal women. Calcif Tissue Int 1994;55:1-7
Cooper C, Shah S, Hand DJ. Screening for vertebral osteoporosis using individual risk factors. Osteoporos Int 1991;2:48-53
Lydick E, Cook K, Turpin J, et al. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care 1998;4:37-48
Koh LKH, Ben Sedrine W, Torralba TP, et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteroporos Int 2001;12:699-705
Weinstein L, Ullery B, Bourguignon C. A simple system to determine who needs osteoporosis screening. Obstet Gynecol 1999;93:757-60
Cadarette SM, Jaglal SB, Murray TM, Evaluation of decision rules for referring women for bone densitometry by dual-energy X-ray absorptiometry. J Am Med Assoc 2001;286:57-3
Michaëlsson K, Bergström R, Mallmin H, et al. Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int 1996;6:120-6
Ben Sedrine W, Chevallier T, Zegels B, et al. Development and assessment of the Osteoporosis Index of Risk to facilitate selection of women for bone densitometry. Gynecol Endocrinol 2002,16: 245-50
Gürlek A, Bayraktar M, Ariyürek M. Inappropriate reference range of peak bone mineral density in dual-energy x-ray absorptiometry: implications for the interpretation of t-scores. Osteoporos Int 2000;11: 809-13
Arlot ME, Sornay-Rendu E, Garnero P, et al. Apparent pre-and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort. J Bone Miner Res 1997; 12:683-90
Jeandel L. L'ostéoporose chez les Femmes Ménopausé es et chez les Sujets Traités par Corticoïdes: Méthodes Diagnostiques et Indications. Service recommandations et rèfè rences professionelles. France: ANAES, 2001
The Swedish Council on Technology Assessment in Health Care. Bone density measurement. A systematic review. J Intern Med 1997;24:1-60
Kanis JA, Johnell O, Oden A, et al. Ten year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 2002;30:251-8
Schott AM, Xerri B. Les Indications des Mesures Quantitatives du Tissu Osseux: Actualisation. Service évaluation des technologies. France: ANAES, 2000